Alison McGregor

Alison McGregor is originally from the UK. She has over 20 years regulatory experience across therapy areas and is used to working with teams globally across sites and regions, including successful leadership of teams through high stakes meetings with both US and EU regulatory authorities. Alison holds a PhD in neuroscience and worked in academia at Carleton University in Ottawa, Canada and at the Karolinska Institute in Stockholm prior to moving into regulatory at the UK MHRA and then to AstraZeneca and BioMarin.